Netrin-1 and dependence receptor proteins and methods of use
AssigneeUniversity of Manitoba
InventorJorg Stetefeld
Life of this patent
Estimating the term…
Abstract
Provided herein are fragments of Netrin-1 proteins, fragments of DCC proteins and NEO1 proteins, and antibodies to epitopes located within the fragments of Netrin-1, DCC, and/or NEO1. Also provided herein are methods for using the fragments and antibodies, including methods for inhibiting binding of Netrin-1 to an UNC5 protein, a DCC protein, and/or a NEO1 protein. Other methods provided herein include inducing apoptosis of a cell, and reducing formation of multimers of Netrin-1 proteins, and treating a subject having a cancer or at risk of having a cancer.
Claims30
A NET1 fragment comprising an amino acid sequence having at least 80% identity to amino acids CNLHARRCRFNMELYKLSGRKSGGVCLN (SEQ ID NO:16),
- wherein the NET1 fragment comprises an UNC5 binding domain HARRCR, wherein the UNC5 binding domain comprises conservative substitutions in HARRCR at positions 1, 2, 3, 4, 5, 6, or a combination thereof,
- wherein the NET1 fragment comprises a DCC/NEO1 binding domain MELYKLS, wherein the DCC/NEO1 binding domain comprises conservative substitutions in MELYKLS at positions 1, 2, 3, 4, 5, 6, 7, or a combination thereof, and
- wherein the NET1 fragment comprises UNC5 binding activity and DCC/NEO1 binding activity.
A DCC/NEO1 fragment comprising an amino acid sequence having at least 80% identity to amino acids MMPPVGVQASILSHDTIRITWADNSLPKHQKITDSRYYTVRWKTNIPANTKYKNANATT LSYLVTGLKPNTLYEFSVMVTKGRRSSTWSMTAHGATFELVP (SEQ ID NO:18) or MLPPVGVQAVALTHEAVRVSWADNSVPKNQKTSDVRLYTVRWRTSFSASAKYKSEDT TSLSYTATGLKPNTMYEFSVMVTKNRRSSTWSMTAHATTYEAAP (SEQ ID NO:19),
- wherein the DCC/NEO1 fragment comprises a NET1 binding domain MVTK(N/G)RRSSTWS, wherein the NET1 binding domain comprises conservative substitutions in MVTK(N/G)RRSSTWS at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, or a combination thereof,
- wherein the DCC/NEO1 fragment comprises NET1 binding activity.
An antibody that specifically binds an epitope located within an amino acid sequence HARRCR or MELYKLS.
An antibody that specifically binds an epitope located within an amino acid sequence MVTK(N/G)RRSSTWS.
An antibody that specifically binds to an epitope located within an amino acid sequence of a V-2 fragment CNLHARRCRFNMELYKLSGRKSGGVCLN (SEQ ID NO:16).
An antibody that specifically binds to an epitope located within an amino acid sequence of a the V-2 region CNCNLHARRCRFNMELYKLSGRKSGGVCLNCRHNTAGRHCHYCKEGXYRDMGKPITH RKACKAC (SEQ ID NO:
- 17), where the amino acid X is F or Y.
(canceled)
-28. (canceled)
A NET1 fragment that comprises an alteration of an amino acid corresponding to L359, E385, T415, 1452, or a combination thereof, of a NET1 protein, wherein the NET1 fragment will not form a multimer.
-38. (canceled)
Dependencies are inferred from the claim text.